De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes.
Zhu Y, Meng J, Feng B, Zhao Y, Zang Y, Lu L, Su M, Yang Q, Zhang Q, Feng L, Zhao J, Shao M, Ma Y, Yang X, Yang H, Li J, Jiang X, Rao Z.
Zhu Y, et al. Among authors: ma y.
Structure. 2024 Sep 5;32(9):1327-1334.e3. doi: 10.1016/j.str.2024.05.019. Epub 2024 Jun 25.
Structure. 2024.
PMID: 38925121